Although faecal and endoscopic tests appear to be effective in reducing colorectal cancer incidence and mortality, further technological and organizational advances are expected to improve the performance and acceptability of these tests. Several attempts to improve endoscopic technology have been made in order to improve the detection rate of neoplasia, especially in the proximal colon. Based on the latest evidence on the long-term efficacy of screening tests, new strategies including endoscopic and faecal modalities have also been proposed in order to improve participation and the diagnostic yield of programmatic screening. Overall, several factors in terms of both efficacy and costs of screening strategies, including the high cost of bio...
textabstractColorectal cancer (CRC) is the third most common cancer and the second leading cause of ...
Introduction; Rectal cancer is the third leading cancer in the world in terms of incidence and morta...
Colorectal cancer (CRC) is the most common cancer in Taiwan, and is the third leading cause of cance...
Although faecal and endoscopic tests appear to be effective in reducing colorectal cancer incidence ...
Background. Worldwide, colorectal cancer (CRC) is the third most common cancer in men and second mos...
Opinion statementColorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also...
INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females...
textabstractColorectal cancer (CRC) forms an important public health problem, especially in develope...
Colorectal cancer (CRC) is a major health burden. Screening can reduce both incidence and mortality ...
Much interest has been generated in the last few years with regard to new gastro-intestinal imaging ...
textabstractColorectal cancer (CRC) screening is a rapidly moving field. This thesis provides strate...
Objective: New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting trials w...
OBJECTIVE: New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting trials w...
Since 1997, there has been a consensus that screening iseffective in reducing colorectal cancer mort...
Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on the effectiveness o...
textabstractColorectal cancer (CRC) is the third most common cancer and the second leading cause of ...
Introduction; Rectal cancer is the third leading cancer in the world in terms of incidence and morta...
Colorectal cancer (CRC) is the most common cancer in Taiwan, and is the third leading cause of cance...
Although faecal and endoscopic tests appear to be effective in reducing colorectal cancer incidence ...
Background. Worldwide, colorectal cancer (CRC) is the third most common cancer in men and second mos...
Opinion statementColorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also...
INTRODUCTION: Colorectal cancer (CRC) is the third most common cancer in males and second in females...
textabstractColorectal cancer (CRC) forms an important public health problem, especially in develope...
Colorectal cancer (CRC) is a major health burden. Screening can reduce both incidence and mortality ...
Much interest has been generated in the last few years with regard to new gastro-intestinal imaging ...
textabstractColorectal cancer (CRC) screening is a rapidly moving field. This thesis provides strate...
Objective: New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting trials w...
OBJECTIVE: New screening tests for colorectal cancer (CRC) are rapidly emerging. Conducting trials w...
Since 1997, there has been a consensus that screening iseffective in reducing colorectal cancer mort...
Recent 15-year updates of sigmoidoscopy screening trials provide new evidence on the effectiveness o...
textabstractColorectal cancer (CRC) is the third most common cancer and the second leading cause of ...
Introduction; Rectal cancer is the third leading cancer in the world in terms of incidence and morta...
Colorectal cancer (CRC) is the most common cancer in Taiwan, and is the third leading cause of cance...